01 Feb 2012 Total Voting Rights

01 Feb 2012 Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases

31 Jan 2012 Full Year 2011 results date notification – February 9, 2012

23 Jan 2012 Notification of major interests in shares (27KB PDF)

10 Jan 2012 Shire Acquires US Rights to Resolor® (prucalopride)

05 Jan 2012 Shire’s VENVANSE® (lisdexamfetamine dimesylate) Marketing Application accepted for review in Europe

03 Jan 2012 Total Voting Rights